Citigroup Inc news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

C 52.42 +0.01 (0.02%)
price chart
Citigroup Inc. Probed By More Authorities
Disclosed in an annual filing with the Securities and Exchange Commission (SEC), Citigroup Inc. (NYSE:C) has been asked for details on the firm's compliance with the anti-money laundering laws and the Bank Secrecy Act by California Department of ...
Citigroup (C) Stock Climbs Today On Lowered Legal Cost Estimates
Treasury, California Regulators Probing Citigroup's Banamex  Wall Street Journal
Apple Watch To Launch April 16: Citigroup Inc
Citigroup analysts are expecting Apple Inc. to debut its much anticipated Apple Watch on April 16. The firm believes the iPhone maker's March 9 event will be entirely focused on the Apple Watch.
Citigroup unit probed by more authorities over money laundering
NEW YORK (Reuters) - Citigroup Inc (C.N) said additional government authorities have started probes of possible breaches of anti-money laundering laws at its Banamex USA unit.
Will Citigroup Inc. Pass The Fed's Stress Test
All eyes are on Citigroup Inc. as the Federal Reserve is set to release its bank stress test. The Federal Reserve carries out an annual Comprehensive Capital Analysis and Review (CCAR) and Bank Stress Test exercise to assess banks' risk management.
Why Citigroup Inc. Shares Slumped 13% in January
What: Shares of Citigroup (NYSE: C ) , a global banking and financial services giant, slumped 13% in January, based on data from S&P Capital IQ, following a weaker than expected fourth-quarter earnings report.
Citigroup Inc. Increases Genesee & Wyoming Price Target to $114.00 (GWR)
Genesee & Wyoming logo Investment analysts at Citigroup Inc. increased their price target on shares of Genesee & Wyoming (NYSE:GWR) from $93.00 to $114.00 in a note issued to investors on Friday.
Bank of America Upgrades Genesee & Wyoming to "Buy" (GWR)  Intercooler
BioMarin Pharmaceutical Inc. Price Target Raised To $133 At Citigroup
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has been rated a �Buy� by equities researchers at Citigroup Inc., in a recent report published on February 25.
BioMarin Pharmaceutical Rating Reiterated by Citigroup Inc. (BMRN)  Mideast Time
BioMarin Pharmaceutical Given New $133.00 Price Target at Citigroup Inc ...  WKRB News
It's Almost Citigroup's Time To Shine (C)
With a recent upgrade from Deutsche, the stock has doubled the S&P 500 in that time. There are high hopes that the bank will get approved to return capital to shareholders in the form of a dividend and share repurchase program this time around.
Why Citigroup Inc. (NYSE:C) thinks Apple Inc. (NASDAQ:AAPL) is a good ...
Investment firm, Citigroup Inc.(NYSE:C) discussed its opinion regarding Apple Inc.'s (NASDAQ:AAPL) stock in one of its research reports which it sent out to investors and clients.
Associated British Foods plc Given "Buy" Rating at Citigroup Inc. (ABF)
Associated British Foods plc logo Citigroup Inc. reissued their buy rating on shares of Associated British Foods plc (LON:ABF) in a research report released on Friday morning.